Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0001193125-26-082533

Director sold 50,000 shares at an average $7.01 ($350,253)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Thomas Stephen Basil · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-25 Sale : show line 1 in the form 10b5-1 −33,687 $7.00 $235,964 170,970 D
2026-02-26 Sale : show line 2 in the form 10b5-1 −16,313 $7.01 $114,289 154,657 D
Open-market sales · 50,000 sh · avg $7.01 · $350,253
Loading xslF345X05/ownership.xml…